EMCURE - Swing Trade Analysis with AI Signals
Back to ListSwing Trade Rating: 3.7
| Stock Code | EMCURE | Market Cap | 27,871 Cr. | Current Price | 1,471 ₹ | High / Low | 1,586 ₹ |
| Stock P/E | 41.9 | Book Value | 170 ₹ | Dividend Yield | 0.20 % | ROCE | 13.5 % |
| ROE | 11.6 % | Face Value | 10.0 ₹ | DMA 50 | 1,474 ₹ | DMA 200 | 1,400 ₹ |
| Chg in FII Hold | 0.30 % | Chg in DII Hold | 1.74 % | PAT Qtr | 282 Cr. | PAT Prev Qtr | 118 Cr. |
| RSI | 48.6 | MACD | 6.04 | Volume | 94,626 | Avg Vol 1Wk | 2,08,767 |
| Low price | 889 ₹ | High price | 1,586 ₹ | PEG Ratio | -3.10 | Debt to equity | 0.50 |
| 52w Index | 83.5 % | Qtr Profit Var | 462 % | EPS | 33.7 ₹ | Industry PE | 27.2 |
📊 EMCURE shows strong earnings momentum with PAT rising sharply (282 Cr. vs 118 Cr.), supported by EPS of 33.7 ₹. Fundamentals are decent, with ROCE (13.5%) and ROE (11.6%) showing moderate efficiency. The stock trades at a premium P/E of 41.9 compared to industry average (27.2), but recent profit growth justifies some of this. Technicals are neutral-to-positive (RSI 48.6, MACD 6.04), with price hovering near DMA 50 (1,474 ₹). This makes EMCURE a reasonably good candidate for swing trading with cautious entry.
💡 Optimal Entry Price: Around 1,450–1,470 ₹ (near DMA 200 support at 1,400 ₹).
📉 Exit Strategy (if already holding): Consider booking profits near 1,550–1,570 ₹ (close to recent high 1,586 ₹) unless momentum strengthens further.
Positive
- Strong quarterly PAT growth (+462%) highlights earnings momentum.
- EPS of 33.7 ₹ supports valuation strength.
- DII holdings increased (+1.74%), showing domestic institutional confidence.
- Technical indicators (MACD positive, RSI near neutral) suggest potential upside.
Limitation
- P/E of 41.9 is higher than industry average (27.2), indicating premium valuation.
- ROCE (13.5%) and ROE (11.6%) are moderate compared to peers.
- PEG ratio (-3.10) suggests growth valuation concerns.
- Volume lower than average (94,626 vs 2,08,767), showing reduced trading interest.
Company Negative News
- FII holdings decreased (-3.01%), showing reduced foreign investor confidence.
- Debt-to-equity ratio at 0.50 is higher than ideal, adding leverage risk.
Company Positive News
- Quarterly PAT surged significantly (282 Cr. vs 118 Cr.).
- DII holdings increased (+1.74%), reflecting domestic support.
- Stock trading near DMA support, offering potential rebound opportunity.
Industry
- Industry P/E is 27.2, lower than EMCURE’s 41.9, showing premium valuation.
- Pharma sector remains strong, supported by healthcare demand and growth opportunities.
Conclusion
✅ EMCURE is a moderately strong swing trade candidate. Strong earnings growth and institutional support balance out premium valuation and moderate fundamentals. Entry near 1,450–1,470 ₹ offers favorable risk-reward, with exit targets around 1,550–1,570 ₹. A strict stop-loss near 1,420 ₹ is advisable to manage downside risk.